FDA Approved: TRETINOIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's supplemental application for tretinoin (generic) under ANDA 208279, authorizing continued or expanded marketing of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Acute Promyelocytic Leukemia

Drugs mentioned

• TRETINOIN (TRETINOIN)

Snippet

SUPPL AP for TRETINOIN (TRETINOIN)